These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis. Yin H; Distler O; Shen L; Xu X; Yuan Y; Li R; Liu B; Li Q; Huang Q; Xie F; Zhang Z; Liang R; Dai X; Chen X; Li B; Yan Q; Lu L Arthritis Rheumatol; 2024 Jan; 76(1):78-91. PubMed ID: 37488975 [TBL] [Abstract][Full Text] [Related]
8. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects. Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N; J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885 [TBL] [Abstract][Full Text] [Related]
9. The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients. Lenna S; Assassi S; Farina GA; Mantero JC; Scorza R; Lafyatis R; Farber HW; Trojanowska M Arthritis Res Ther; 2015 Dec; 17():363. PubMed ID: 26669670 [TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Higley H; Persichitte K; Chu S; Waegell W; Vancheeswaran R; Black C Arthritis Rheum; 1994 Feb; 37(2):278-88. PubMed ID: 7510487 [TBL] [Abstract][Full Text] [Related]
12. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect. Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ; Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492 [TBL] [Abstract][Full Text] [Related]
13. Identification of key genes and immune profile in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension by bioinformatics analysis. Zhang T; Huang C; Luo H; Li J; Huang H; Liu X; Zhan S Life Sci; 2021 Apr; 271():119151. PubMed ID: 33539912 [TBL] [Abstract][Full Text] [Related]
14. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis. Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743 [TBL] [Abstract][Full Text] [Related]
15. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis. Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis. Corallo C; Pinto AM; Renieri A; Cheleschi S; Fioravanti A; Cutolo M; Soldano S; Nuti R; Giordano N Clin Exp Rheumatol; 2019; 37 Suppl 119(4):69-75. PubMed ID: 31365333 [TBL] [Abstract][Full Text] [Related]
17. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients. Martínez-Godínez MA; Cruz-Domínguez MP; Jara LJ; Domínguez-López A; Jarillo-Luna RA; Vera-Lastra O; Montes-Cortes DH; Campos-Rodríguez R; López-Sánchez DM; Mejía-Barradas CM; Castelán-Chávez EE; Miliar-García A Isr Med Assoc J; 2015 Jan; 17(1):5-10. PubMed ID: 25739168 [TBL] [Abstract][Full Text] [Related]
18. Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis. Clark KE; Lopez H; Abdi BA; Guerra SG; Shiwen X; Khan K; Etomi O; Martin GR; Abraham DJ; Denton CP; Stratton RJ Arthritis Res Ther; 2015 Mar; 17(1):73. PubMed ID: 25885360 [TBL] [Abstract][Full Text] [Related]
19. Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin. Mathes AL; Christmann RB; Stifano G; Affandi AJ; Radstake TR; Farina GA; Padilla C; McLaughlin S; Lafyatis R Ann Rheum Dis; 2014 Oct; 73(10):1864-72. PubMed ID: 23873879 [TBL] [Abstract][Full Text] [Related]
20. Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms. Mahoney JM; Taroni J; Martyanov V; Wood TA; Greene CS; Pioli PA; Hinchcliff ME; Whitfield ML PLoS Comput Biol; 2015 Jan; 11(1):e1004005. PubMed ID: 25569146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]